Corcept Therapeutics told investors the Inflation Reduction Act's inflation rebates may materially cut its revenue and profits in 2026 and beyond, one of the sharpest company-specific warnings in a filing season otherwise dominated by boilerplate recitations of the same 2022 law.

The cancer diagnostics company will add Convergent’s UroAmp urinary tumor DNA platform, with up to $30 million more tied to reimbursement milestones.

The all-cash purchase is expected to firm up the education company’s graduate health sciences portfolio as early as April 2027.

The independent refiner took ownership of West Coast hydrogen plants that will run under Torrance Refining after a transition with Air Products.

The autonomous-systems company said the Israeli target adds a mission-critical layer to its Precision Strike platform and widens engineering and customer reach across allied markets.

The Giddings operator said the deal more than doubles its net acreage and creates a dominant Eagle Ford/Austin Chalk position in South Texas.

The home-care provider said the asset purchase would add about $280 million in annualized personal care revenue, a roughly 19% lift to its revenue base.

American Eagle halted program repurchases while Broadcom, Academy Sports and RH kept authorizations moving.

The retailer raised 2026 comparable-sales guidance to 1.0%–1.5% after a fifth straight quarter of gains.

First-quarter net sales were $331 million as price gains were offset by volume declines, and earnings fell to $.50 a share.

The Southeast regional lender will pay $10.50 a share in cash and stock, a 25% premium to First Community’s September 9 close.

The peripheral-nerve-repair company said the purchase of NerveTape, the first FDA-approved sutureless repair device, will broaden its addressable market.

GAAP net revenues were $922.2 million in the quarter ended August 1, 2026, up 2.6% from a year earlier and 4.2 points faster than the first quarter.

Net sales were $330.7 million in the first quarter of fiscal 2027 as a 7.1% price increase offset a 6.4% drop in case volume.

The combination of two Midwest utilities is structured as a merger of equals that would create a parent named Bright Horizon Energy.

The all-stock combination of two middle-market apartment REITs is expected to be about 5% accretive to 2027 Core FFO per share on a leverage-neutral basis.

The customer-engagement platform posted $227.2 million of sales and $22.0 million of non-GAAP operating income in the fiscal second quarter.

The metals processor said it is combining with Kloeckner to realize opportunities ahead in the metals-processing business.

The Seattle-based lender said the all-stock combination is expected to be significantly accretive to earnings per share in 2027.

The Houston power-infrastructure company said the deal adds specialized EPC and heavy civil construction to its full-cycle offering.

The pump maker closed a mixed cash-and-stock purchase that adds high-pressure technology and an industry-leading brand to its commercial and industrial flow control platform.

Sonida Senior Living put a dollar figure on labor inflation that most peers still describe only in hedged, forward-looking terms.

The company now sees full-year adjusted EPS of $3.95 to $4.10 after a record $2.3 billion quarter and lifted free-cash-flow expectations to about $210 million.

Abercrombie and Snowflake spent billions on repurchases while Best Buy, Dillard's, and Victoria's Secret paused or slowed.

The voice-AI company said the combination pairs its agentic voice platform with LivePerson’s digital messaging to create an end-to-end omnichannel engagement stack.

The apparel company posted second-quarter non-GAAP earnings of $3.70 a share, above its $3.00 to $3.10 outlook.

The off-price retailer posted $1.42 a share and cut full-year sales guidance to $2.928 billion to $2.941 billion.

The regional lender said the all-cash asset purchase of the commercial banking unit is expected to close early in the fourth quarter of 2026.

The DevSecOps platform guided third-quarter revenue to $281 million to $283 million, below the $286.3 million it reported for the quarter ended July 31.

The materials science maker lifted third-quarter adjusted EPS guidance to a range of $1.40 to $1.50 after reversing a CH-53K loss reserve.